COLRF (Tian An Medicare) 3-Year RORE % : 300.00% (As of Dec. 2025)


COLRF Tian An Medicare Ltd COLRF
45 GF Score
Price $0.08
GF Value $0.07
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare 3-Year RORE %?

Tian An Medicare COLRF 45 3-Year RORE % is 300.00 as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 45/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Tian An Medicare ranks better than 97.19% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Tian An Medicare's 3-Year RORE % for the quarter that ended in Dec. 2025 was 300.00%.

The industry rank for Tian An Medicare's 3-Year RORE % or its related term are showing as below:

COLRF's 3-Year RORE % is ranked better than
97.19% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs COLRF: 300.00

Tian An Medicare  (OTCPK:COLRF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Tian An Medicare 3-Year RORE % Related Terms


Tian An Medicare 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Tian An Medicare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tian An Medicare 3-Year RORE % Chart

Tian An Medicare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 4.62 -59.09 -152.94 300.00

Tian An Medicare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.09 -82.76 -152.94 -145.45 300.00

COLRF vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Tian An Medicare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tian An Medicare 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Tian An Medicare's 3-Year RORE % falls into.


COLRF
45GF Score
Tian An Medicare Ltd COLRF
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare 3-Year RORE % Calculation

Tian An Medicare's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.004-0.002 )/( 0.002-0.004 )
=-0.006/-0.002
=300.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 300.00 mean?
Tian An Medicare (COLRF) has a 3-Year RORE % of 300.00 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tian An Medicare and its competitors. According to the industry distribution chart, Tian An Medicare ranks #17 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 2.8%.
Is Tian An Medicare's 3-Year RORE % too high?
Tian An Medicare's current 3-Year RORE % is 300.00. Based on the distribution chart, Tian An Medicare ranks #17 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tian An Medicare has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #17 out of 605 companies for 3-Year RORE %. This places Tian An Medicare in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tian An Medicare and its competitors. Tian An Medicare's current 3-Year RORE % is 300.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current 3-Year RORE % of 300.00. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current 3-Year RORE % is 300.00. Tian An Medicare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current 3-Year RORE % is 300.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (COLRF) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.

Key valuation signals for COLRF:

  • 3-Year RORE %: 300.00
  • GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tian An Medicare Business Description

Other Exchanges 00383:Hong KongSMI:Germany
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
45GF Score

Get the complete analysis for COLRF

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.07
GF Value